Author information:
(1)The University of Toledo College of Medicine & Life Sciences, Toledo, 
OH 43606, USA.
(2)ProMedica Health System, Toledo, OH 43606, USA.
(3)West German Cancer Center, Deparment of Medical Oncology, University Hospital 
Essen, University of Duisburg-Essen, Essen, Germany.
(4)Centre Léon Bérard, Unicancer, LYRICAN and Université Claude Bernard Lyon 1, 
Lyon, France.
(5)Leiden University Medical Center, Leiden, The Netherlands.
(6)Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
(7)University Hospitals Leuven, Department of General Medical Oncology, Leuven 
Cancer Institute, Leuven, Belgium.
(8)Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
(9)Department of Epidemiology & Preventive Medicine, School of Public Health & 
Preventive Medicine, Monash University & Department of Medical Oncology Alfred 
Health, Melbourne, Australia.
(10)Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA.
(11)Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health 
& Science University, Portland, OR 97239, USA.